F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
Based on interview and record review the facility failed to follow their control substance policy and ensure
the medication hydrocodone 5-325 milligrams are documented and accounted for, for two of two residents
(R4 and R5) reviewed for controlled medications.
Findings include:
1. On 3/12/25 at 3:20pm during survey tour with assist from V4 (Director of Nursing) to observe the practice
of counting control substance/narcotics, R4's control drug receipt/record/disposition form was observed to
have documented discrepancy below date of 2/18/25.
R4's control drug receipt record denotes Hydrocodone 5-325mg was signed out on 2/4/25 at 9a.m., 1p.m.,
and 9p.m. On 2/5/25 at 10a.m. On 2/6/25 at 2pm, 10pm. On 2/7/25 at 8a.m. and 4p.m. On 2/11/25 at 9a.m,
4p.m. On 2/12/25 at 9a.m, 10p.m. On 2/13/25 at 9a.m, 10p.m, 9p.m. On 2/18/25 at 9a.m, 2p.m.
R4's Medication Administration Record dated February 2025 was reviewed, there is no documentation
denoting that hydrocodone 5-325mg was administered to R4 on 2/4/25 at 9a.m., 1p.m., and 9p.m. On
2/5/25 at 10a.m. On 2/6/25 at 2pm, 10pm. On 2/7/25 at 8a.m. and 4p.m. On 2/11/25 at 9a.m, 4p.m. On
2/12/25 at 9a.m, 10p.m. On 2/13/25 at 9a.m, 10p.m, 9p.m. On 2/18/25 at 9a.m, 2p.m.
R4's physician order sheet shows orders for hydrocodone/APAP tab, 5-325MG (milligrams) give 1 tablet
orally every six hours as needed for pain related to chronic pulmonary disease, order start date 11/1/2024.
On 3/14/25 at 10:39am V4 said control substance should be signed out on the medication administration
record after administration of the medication.
Facility policy dated 10/2014 denotes in-part accurate accountability of the inventory of all controlled drugs
is maintained at all times. When a controlled substance is administrated, the licensed nurse administering
the medication immediately enters the following information on the accountability record and medication
administration record (MAR): date and time of administration. (MAR and accountability record). Amount
administered. (accountability record). Remaining quantity. (accountability record). Initials of the nurse
administering the dose, completed after the medication is actually administered. (MAR, accountability
record).
2. On 3/12/25 at 3:20pm during survey tour with assist from V4 (Director of Nursing) to observe the practice
of counting control substance/narcotics, R5's control drug receipt/record/disposition form was observed to
have documented discrepancy below date of 2/18/25.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
145781
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145781
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/14/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Generations at Applewood
21020 Kostner Avenue
Matteson, IL 60443
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
R5's control drug receipt record denotes Hydrocodone 5-325mg was signed out on 2/4/25 at 9a.m., 2/5/25
at 10p.m., 2/6/25 9a.m., and 10pm, 2/7/25 at 9am, 2/12/25 at 10p.m., 2/13/25 at 9p.m., 2/14/25 at 7p.m,
2/18/25 at 10a.m., 2/19/25 at 10a.m., 2/20/25 at 9am, 2/21/at 10p.m., 2/22/25 at 9a.m., 2/22/25 at 6
(cannot determine if pm or am), 2/23/25 at 9a.m., 2/24/25 at 10a.m.
R5's Medication Administration Record dated February 2025 was reviewed, there is no documentation
denoting that hydrocodone was administered to R5 on 2/4/25 at 9am, 2/5/25 at 10p.m, 2/6/25 at 9am, and
10pm, 2/7/25 at 9am, 2/12/25 at 10pm, 2/13/25 at 9pm, 2/14/25 at 7pm, 2/18/25 at 10a.m., 2/19/25 at
10a.m., 2/20/25 at 9a.m., 2/21/25 at 10p.m., 2/22/25 at 9a.m., 2/22/25 at 6 (cannot determine if pm or am),
2/23/25 at 9a.m., 2/24/25 at 10a.m.
R5's physician order sheet shows and order for Norco oral tablet 5-325 mg (hydrocodone-acetaminophen)
give 2 tablets by mouth 6 hours as needed for mod to severe pain, order date 1/27/25.
R5's physician order sheet shows and order for Norco oral tablet 5-325 mg (hydrocodone-acetaminophen)
give 1 tablet by mouth 6 hours as needed for mild pain, order date 1/27/2025.
On 3/14/25 at 9:44am R5 observed sitting in her wheelchair in her room, R5 observed alert to person,
place and situation. R5 said her pain medication is scheduled as needed. R5 said she did not request or
ask to take Norco multiple times in February.
On 3/14/25 at 10:39am V4 said control substance should be signed out on the medication administration
record after administration of the medication.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145781
If continuation sheet
Page 2 of 2